• Built on the EA3826 recognized expertise and to answer the increasing requests coming from public/private partners, the CRO company Atlangram had been created in June 2011 by Dr Jocelyne Caillon, Pr Gilles Potel and Dr Cédric Jacqueline. In 2013, Pr Karim Asehnoune joined the company as associate.


  • 2 licences are currently granted to evaluate the impact of TLR4 and TLR9 agonist use in the prevention of infectious complications in post-traumatic immunodepression (PCT/EP2010/070111).
  • Patent: Cytological methods using the autofluorescence of white blood cells for early diagnosis and monitoring (PCT/EP2012/055127).